Use of Diltiazem in Chronic Rate Control for Atrial Fibrillation: A Prospective Case-Control Study

Use of Diltiazem in Chronic Rate Control for Atrial Fibrillation: A Prospective Case-Control Study

Atrial fibrillation (AF) is a multifaceted disease requiring personalised treatment. The aim of our study was to explore the prognostic impact of a patient-specific therapy (PT) for rate control, including the use of non-dihydropyridine calcium channel blockers (NDDC) in patients with heart failure...

Full description

Bibliographic Details
Main Authors: Igor Diemberger, Alberto Spadotto, Giulia Massaro, Martina Amadori, Liviu Damaschin, Cristian Martignani, Matteo Ziacchi, Mauro Biffi, Nazzareno Galiè, Giuseppe Boriani
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Biology
Subjects:
personalised therapy
calcium channel blockers
beta-blockers
survival
mortality
Online Access:https://www.mdpi.com/2079-7737/12/1/22

Internet

https://www.mdpi.com/2079-7737/12/1/22

Similar Items